Home » Topics » Disease categories and therapies » Immune

Immune
RSS

EMEA marketing approval for Triacelluvax

Feb. 4, 1999

New immunomodulator LK-423 possesses unique pharmacological properties

Feb. 3, 1999

Clinical trials for Japanese immunosuppressant begin in Europe

Feb. 3, 1999

Priority review status assigned to Rapamune immunosuppressive therapy

Feb. 3, 1999

New herpes vaccine from Cel-Sci proves effective in protecting mice

Feb. 1, 1999

OraVax, Peptide Therapeutics and Pasteur Merieux Connaught announce agreements

Feb. 1, 1999

Antex Biologics successfully completes phase I study of Helicobacter vaccine

Jan. 29, 1999

Yoshitomi's new immunosuppressive agents for arthritis, autoimmune diseases and transplant rejection

Jan. 27, 1999

Another significant market introduction for basiliximab

Jan. 25, 1999

Glaxo Wellcome and PowderJect expand DNA vaccine collaboration

Jan. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...